Article
A novel ferronucleoside that targets DNA replication in pancreatic cancer cells
2021-07-22
Abstract excerpt
<title>Abstract</title> <p>Pancreatic ductal adenocarcinoma (PDAC) is a disease that remains largely refractory to existing treatments including the nucleoside analogue gemcitabine. In the current study we demonstrate that the ferronucleoside 1-(S,Rp) is cytotoxic in a panel of PDAC cell lines including gemcitabine resistant MIAPaCa2, with IC50 values comparable to cisplatin. Biochemical studies show that the mec...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 24b15bde-73fe-5213-b866-2e143bf8ae87
- DOI
- 10.21203/rs.3.rs-741964/v1
